Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: opioid

FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval

Michele B. Kaufman, PharmD, BCGP  |  March 7, 2018

After reviewing a 10-year study, the FDA cautions that prescribing clarithromycin to patients with heart disease increases the risk of heart problems or death…

Filed under:Drug Updates Tagged with:acute painantibioticsApadazclarithromycinHeart Disease

What’s Driving the Pain? Alternative Approaches to Pain Management

Richard Quinn  |  February 26, 2018

Patients can experience many different types of pain, and some patients with chronic pain may believe that only opioids will help them. According to Kelly Weselman, MD, the best way to begin managing pain is to determine its root cause and communicate with the patient about the best approach(es) for decreasing their specific pain…

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:Chronic painchronic pain patientsopioid alternativesOpioidsPainPain Management

Chronic Pain Research Probes Neurologic Pain Pathways, Biomarkers

Mary Beth Nierengarten  |  February 18, 2018

With the aid of increasingly sophisticated neuroimaging technology, research into how the brain activates and changes in patients with chronic pain is delivering fascinating information that will hopefully pave the way to tailored, individual treatment of chronic pain. Over the past several years, data from neuroimaging studies have provided a new understanding of what occurs…

Filed under:ConditionsPain SyndromesResearch Rheum Tagged with:Chronic painneuroimagingPain ManagementResearch

Marijuana for Rheumatology Patients?

Larry Beresford  |  February 17, 2018

SAN DIEGO—What does cannabis offer to the treatment and management of rheumatology patients and the range of pain states they experience? What do we really know about its long-term effects? These are hard questions to answer with currently available data and a reality nuanced by complications cannabis advocates don’t always recognize, according to two experts…

Filed under:Drug UpdatesMeeting Reports Tagged with:ACR/ARHP Annual MeetingcannabisDrug UpdatesmarijuanaPain Management

Persistent Pain Merits Better Access to Psychosocial Care, Group Says

Will Boggs MD  |  February 14, 2018

NEW YORK (Reuters Health)—People with persistent pain need better access to psychosocial care, according to a position statement from the Society of Behavioral Medicine (SBM). “Psychosocial approaches to pain management need to be available for all individuals with persistent pain in all healthcare settings,” Dr. E. Amy Janke from the University of the Sciences, in…

Filed under:Conditions Tagged with:persistent painSociety of Behavioral Medicine (SBM)

FDA Receives Reports of Loperamide Abuse

Michele B. Kaufman, PharmD, BCGP  |  February 14, 2018

The FDA is seeking to limit the number of loperamide doses per package due to reports of heart-related problems and death from the misuse and abuse of the treatment…

Filed under:Drug Updates Tagged with:abuseDrug SafetyFDAloperamideSafetyU.S. Food and Drug Administration (FDA)

Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More

Michele B. Kaufman, PharmD, BCGP  |  January 31, 2018

The FDA has designated upadacitinib a breakthrough therapy to treat adults with moderate to severe atopic dermatitis…

Filed under:ConditionsDrug UpdatesPsoriatic Arthritis Tagged with:abataceptAddictionaddiction treatmentbuprenorphineCAM2038Psoriatic ArthritisU.S. Food and Drug Administration (FDA)upadacitinib

U.S. Senate Votes to Confirm Azar as Health Secretary

Reuters Staff  |  January 24, 2018

WASHINGTON (Reuters)—The U.S. Senate on Wednesday voted to confirm former pharmaceutical industry executive and lobbyist Alex Azar as the next Health and Human Services secretary. Azar will oversee the Trump administration’s response to the opioid epidemic, its efforts to weaken the Affordable Care Act, commonly called Obamacare, and address rising prescription drug prices. The Senate…

Filed under:Uncategorized Tagged with:Alex AzarHealth and Human Services secretary

2017 ACR/ARHP Honors & Awards, Part 2

Richard Quinn  |  January 19, 2018

SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ARHP winners about their individual contributions. In addition, we profile the new class…

Filed under:Meeting ReportsProfessional Topics Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)Awards

Tips for Treating Lupus-Related Renal Disease, Pain, Alopecia

Susan Bernstein  |  January 19, 2018

SAN DIEGO—Rheumatologists who treat lupus patients gleaned tips on diagnosis and management of renal disease, painful neuropathies and alopecia at a “Curbside Consults” session held Nov. 6 at the ACR/ARHP Annual Meeting in San Diego. Membranous Lupus Nephritis Patients with refractory membranous lupus nephritis (MLN), or Class V lupus nephritis, face “significant morbidity, most of…

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:AC&RACR/ARHP Annual MeetingalopeciaAmerican College of Rheumatology (ACR)LupusPainpatient careRenalrheumatologistTreatment

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 32
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences